Frank Bringstrup

Frank Bringstrup has over 30 years of work experience in the healthcare and pharmaceutical industry. Frank is currently serving as the Vice President of Regulatory Affairs at Calliditas Therapeutics AB since February 2019. Prior to this role, Frank worked at Novo Nordisk for 17 years, where they held various positions, including Senior Global Regulatory Lead, Associate Regulatory Project Manager, Regulatory Professional, and Safety Surveillance Adviser. Before joining Novo Nordisk, they worked as a Senior Management Consultant at Lisberg Management Consulting/Muusmann Research and Consulting A/S. Frank also served as a Medical Adviser/Consultant at Frederiksborg County, Public Health Care Management, and as a Medical Adviser at Danish National Board of Health. Frank began their career in the healthcare sector by practicing as a Clinical MD in hospitals in Copenhagen.

Frank Bringstrup's education history includes multiple degrees and diplomas. In 1981, they graduated from Københavns Universitet - University of Copenhagen with a MD degree. After a gap of several years, they pursued further education and from 2004 to 2008, they attended the University of Warwick - Warwick Business School, where they earned a diploma in Business Administration and Management, General. In 2014 and 2015, Frank studied at Copenhagen Business School, obtaining a diploma in Managing Medical Product Innovation (MMPI). Additionally, in 1980 and 1981, they attended Roskilde Handelsskole, where they completed their Business High School degree.